David S. Friedman, MD, PhD, MPH, Named Next Incumbent of the Edith Ives Cogan Professor of Ophthalmology
Dr. Friedman joined the department in the spring of 2019 and was previously the Alfred Sommer Professor of Ophthalmology at the Wilmer Eye Institute of Johns Hopkins University School of Medicine. Dr. Friedman is world-renowned for his contributions to our understanding of the mechanisms, epidemiology, and prevention of angle-closure glaucoma. Over the last 20 years, hehas worked closely with researchers in Singapore, Guangzhou, Beijing, and south India on this research. He identified novel dynamic risk factors for angle closure. His work formed the foundation for two seminal studies of angle-closure glaucoma treatment, including the EAGLE Trial and the Zhongshan Angle Closure Prevention (ZAP) study, both published in the Lancet. Dr. Friedman was a key member of the EAGLE Trial study team, a pivotal research study demonstrating that early lens extraction effectively treats angle-closure glaucoma. He was the co-principal investigator of the ZAP study, which screened over 10,000 individuals to determine if prophylactic laser iridotomy effectively prevents angle closure glaucoma.
Dr. Friedman has published over 450 peer-reviewed articles and has served on the editorial boards of Ophthalmology, the Cochrane Collaboration, and the Journal of Glaucoma. He is a member of the Glaucoma Research Society (limited to the 100 leading glaucoma researchers) and the Alcon Research Institute (composed of the top 6 researchers in ophthalmology each year).